Asia Pacific's Leading MedTech Conference

Helsy Pahlemy is a Pharmacist from University of Indonesia. She got a bachelor degree and Magister Program from University of Indonesia. She start career as government employee at Medical Devices Division. She loves to playing tennis dan having guitar lesson on her free time. Rigt Now, she is responsible on sertification on Medical Devices Distributor.

With more than a decade of extensive international experience working in Asian and African countries, Yizhi Lin is a highly regarded expert in the field of Point-of-Care molecular diagnostic Testing. He serves as a council member for the 12th session of the Chinese Anti-Tuberculosis Association and is a founding committee member of the Genetic Testing Subsection of the Chinese Medical Equipment Association. Additionally, he has made significant contributions to medical and telecommunications sectors as an investor and industry expert.Lin and his team have been instrumental in driving innovation in POCT technology, resulting in numerous patent applications and significant contributions to global health initiatives, including the response to COVID-19 and tuberculosis.

Dr Abhishek is a physician, economist, and international affairs graduate with over five years of experience in clinical medicine, community health, academia and multilateral non-governmental organizations. He has worked with patients from socio-economically disadvantaged populations and supported diagnosis, treatment, and continuous care in the domains of maternal and child nutrition, paediatric cancer, chronic paediatric blood disorders, among others. His passion to solve global health challenges and specifically to improve access to healthcare in Low- and Middle-Income Countries has driven him in his academic and experiential pursuits. Currently, he is serving as the Director for The Voices Project, an independent multilateral healthcare research and policy shaping platform in Singapore. The platform convenes experts, patient advocates, pharmaceutical firms, government agencies, academic researchers, and non-governmental organizations to uncover insights into public health challenges and create a well-represented discourse with the aim of driving public health policy reform and improving the lives of people.

Jon Bastow helps organisations accelerate innovation across R&D and Access in healthcare. He helps health systems prepare to harness innovation, by optimising settings of care, and improved linkage across diagnostics, treatments, vaccines and other tools.He brings over 35 years of experience, having led projects across multiple diseases. He has held senior roles in pharmaceutical companies and international organisations such as FIND and The Global Fund, building partnerships between private sector healthcare and tech companies, NGO’s and governments addressing major problems of poverty. Jon is a member of the Chartered Institute of Marketing, holds degrees in Biochemistry and Philosophy and has given lectures at IMD, London Business School, INSEAD and the Graduate Institute in Geneva. He also serves on various boards in the healthcare space and beyond.

Currently, Dr. Ming Xu is a Professor and the Dean of the Department of Global Health at School of Public Health of Peking University, as well as the Associate Dean of the Institute for Global Health and Development of Peking University. He has rich work experience in global health and the development of the healthcare industry. He was the Head of the Department for Emerging Economies and previously the Senior Political Advisor for External Relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria in Switzerland. Prior to that, he was the Vice President of China Chamber of Commerce for the Import and Export of Medicines and Health Products under the Ministry of Commerce of China. Earlier, he served in the United Nations Iraq-Kuwait Observation Mission and the Chinese Embassy in the Republic of Korea. When working with the Global Fund, his focus was mainly on the prevention and control of major infectious diseases and health system strengthening in the implementing countries, and building up collaborations with emerging economies in the health field. When working in China, he participated a lot in formulating the policies and regulations of China’s healthcare industry, ranging from the promotion of trade and investment, regulation of medicinal products, to the enhancement of the international competitiveness of companies. He was the chair and PI of key health projects, and the head or member of evaluation groups to review major health projects at the national level. He currently serves as a member of the Technical Advisory Panel (TAP)of the Pandemic Fund and the World Health Organization’s Technical Advisory Group on Local Production and Technology Transfer of Health Products(TAG-LPTT) .

He got a Ph.D. in industrial economics from Fudan University and completed his post-doctoral fellowship at Guanghua School of Management of Peking University. He has written more than one hundred papers and articles in journals and specialized publications.

Prof. Lan Yao, Dean of School of Medicine and Health Management, Tongji Medical College of Huazhong University of Science and Technology, Professor, Doctoral Supervisor, Ministry of Education New Century Excellent Talents, Executive Director of HUST Base of National Institute of Healthcare Security, Director of Primary Health Care Branch of China International Exchange and Promotive Association for Medical and Health Care, Vice Director of Health Insurance Branch of China Health Economics Association, Executive Director of China Health Insurance Research Association, Executive Director of Community Health Association of China, Vice President of Wuhan Medical Insurance Research Association, Vice President of Wuhan Community Health Association, Consulting expert of the Standing Committee of the 15th People’s Congress of Wuhan, Member of the Advisory Committee of Shenzhen Community Health Association. She has served as an advisor to the Health Bureau of the Macao Special Administrative Region. In addition, she was the chief editor of the second edition and third editions of textbook entitled “Medical Security”, with a total of eight books edited. As a project leader, she has presided over more than 80 scientific research projects of the National Natural Science Foundation of China, the National Health Commission, the Ministry of Human Resources and Social Security, the National Development and Reform Commission, the Ministry of Civil Affairs, the Ministry of Science and Technology, the World Health Organization Representative Office in China, the United Nations Children’s Fund, etc. More than 130 academic papers were published in various authoritative journals at home and abroad. She has received 8 awards, including the “China Medical Award” and the Third Prize of Hubei Provincial Scientific and Technological Progress. Main research areas: health economy, health policy, medical security, and primary health care.

Grace Wang is a Partner based in L.E.K.’s Shanghai office. She has over 10 years of experience in strategy consulting, with a focus on the life science and healthcare practice.

Grace has extensive experience supporting international and Chinese clients in medical device, pharmaceutical, life science tools and broader healthcare sectors on a wide range of engagements including growth strategy, pricing and market access, China localization and transaction support​.

Grace graduated from Fudan University with a Double Master’s Degree in International Management from Fudan and Bocconi University​.

Yvonne holds a PhD in Medicine from University of New South Wales and Master of Public Health from Mount Sinai School of Medicine, New York. Her core competencies are real- world clinical evidence generation, health economics, health technology assessments and market access. Yvonne has more than 18 years of working experience across different organizations including academia, government, pharmaceutical and medtech industry. She has established track record publications and worked in the following therapeutic areas: oncology, infectious disease, diabetes, cardiovascular and stroke. She received further training in cancer epidemiology at International Agency for Research on Cancer (IARC), patient centered care at US Patient-Centered Outcome Research Institute (PCORI) and alumni of Eureka 3rd International Certificate Program in Translational Medicine (2010). Yvonne drives multi-stakeholder collaborations to improve patient access to innovative medical technologies across Asia Pacific and she advocates for patient-centered care.

Yawen Wang, M.D., Reviewer, Division of Clinical and Biostatistics I, Center for Medical Device Evaluation (CMDE) of NMPA. She is also a member of Clinical Evaluation Working Group (MDCE) of IMDRF, and participated in the harmonization of Documents of Clinical Evaluation.

Ruslan Tulenov from Kazakhstan, has been living and working in China for 15 years. He is actively engaged in public welfare activities, and has been praised by Chinese President Xi Jinping for donating rare RH-negative blood, also known as “panda blood,” to Chinese patients.

In October 2019, Ruslan Tulenov joined the Hainan International Economic Development Bureau (Hainan IEDB) as the global press officer and deputy director for investment promotion. He has been engaged in promotion of Hainan Free Trade Port, developing relations with foreign investment agencies and broadening global network for Hainan IEDB, trying to help global investors better locate potential projects and partners in the free trade port, and organizing the China International Consumer Products Expo (a.k.a Hainan Expo), the only national-level expo that targets consumer goods.

Studied at Hainan Universtiy and Beijing University of Science and Technology, he holds a bachelor’s degree in Economics.